How Obesity Drugs Affect Body Composition: Muscle, Fat, and Bone Changes
Review of obesity pharmacotherapy effects on body composition examines how GLP-1 and related drugs affect muscle mass, fat distribution, and bone density during weight loss.
Quick Facts
What This Study Found
Review of obesity pharmacotherapy effects on body composition examines how GLP-1 and related drugs affect muscle mass, fat distribution, and bone density during weight loss.
Key Numbers
Review covers liraglutide, semaglutide, tirzepatide, and naltrexone/bupropion. Specific muscle preservation percentages not detailed in abstract.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Review of obesity pharmacotherapy effects on body composition examines how GLP-1 and related drugs a
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- The effect of obesity pharmacotherapy on body composition, including muscle mass.
- Published In:
- International journal of obesity (2005), 49(3), 381-387 (2025)
- Authors:
- Argyrakopoulou, Georgia(3), Gitsi, Evdoxia(2), Konstantinidou, Sofia K, Kokkinos, Alexander
- Database ID:
- RPEP-09974
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Review of obesity pharmacotherapy effects on body composition examines how GLP-1 and related drugs affect muscle mass, fat distribution, and bone density during weight loss.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09974APA
Argyrakopoulou, Georgia; Gitsi, Evdoxia; Konstantinidou, Sofia K; Kokkinos, Alexander. (2025). The effect of obesity pharmacotherapy on body composition, including muscle mass.. International journal of obesity (2005), 49(3), 381-387. https://doi.org/10.1038/s41366-024-01533-3
MLA
Argyrakopoulou, Georgia, et al. "The effect of obesity pharmacotherapy on body composition, including muscle mass.." International journal of obesity (2005), 2025. https://doi.org/10.1038/s41366-024-01533-3
RethinkPeptides
RethinkPeptides Research Database. "The effect of obesity pharmacotherapy on body composition, i..." RPEP-09974. Retrieved from https://rethinkpeptides.com/research/argyrakopoulou-2025-the-effect-of-obesity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.